Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: MYLAN PHARMACEUTICALS INC.

Referral inspection · Health discipline

On , OSHA opened a referral health inspection of MYLAN PHARMACEUTICALS INC. in 781 CHESTNUT RIDGE ROAD, MORGANTOWN, WV 26505 (NAICS 325412). OSHA activity number 311685168.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Mylan Pharmaceuticals INC. — free Get an email when a new federal OSHA severe-injury report for Mylan Pharmaceuticals INC. is published. One employer, no account, unsubscribe in one click.
Site address
781 CHESTNUT RIDGE ROAD
City
MORGANTOWN
State
WV
ZIP
26505
Mailing
POST OFFICE BOX 4310, MORGANTOWN, WV 26505
Inspection type
Referral (C)
Scope
Partial (B)
Discipline
Health
Advance notice
No
Union status
Y
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
325412
SIC code (legacy)
2834
Employees
1800
Ownership type
A

2 citations on file for this inspection.

5(a)(1)

Other-than-serious Gravity 05 1 instance 3 exposed
Issued
Mar 4, 2009
Abate by
Oct 1, 2009
Penalty
Initial $2,975 · Current $1,000 Reduced
Section 5(a)(1) of the Occupational Safety and Health Act of 1970: The
employer did not
furnish employment and a place of employment which were free from
recognized hazards
that were likely to cause death or serious physical harm to the employees
in that employees
were exposed to fire hazards:
(a)NEX 512, Production Area:  On January 22, 2009 and times prior to,
employees were exposed to a fire hazard while charging the fluid bed with
powdered ingredients used in the manufacturing of pharmaceuticals.  The
powdered ingredients were a combustible dust.  The drop tube used for
charging was not equipped with a device to prevent fire from entering into
the
work area from the fluid bed.
NOTE: Among other methods, one feasible and acceptable abatement method to
correct this
hazard is to follow accepted safe practices such as but not limited to;
(a) installation of an
isolation valve between the fluid bed and operator opening of the drop
tube, (b) follow the
guidelines set forth in NFPA 654, Standard for the Prevention of Fire and
Dust
Explosions
from the Manufacturing, Processing, and Handling of Combustible
Particulate Solids.
ABATEMENT CERTIFICATION REQUIRED FOR THIS ITEM
Recent events (2)
  • — I (O) $1000.00
  • — Z (S) $2975.00

1910.132 A

Deleted Serious Gravity 05 1 instance 3 exposed
Issued
Mar 4, 2009
Abate by
Mar 30, 2009
Recent events (2)
  • — I (S)
  • — Z (S)

View Mylan Pharmaceuticals INC.'s full OSHA safety record →

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 311685168.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.